Tocilizumab in Covid-19. Reply
Errataetall: |
CommentOn: N Engl J Med. 2021 Jan 7;384(1):86-87. - PMID 33356049 |
---|---|
Medienart: |
E-Artikel |
Erscheinungsjahr: |
2021 |
---|---|
Erschienen: |
2021 |
Enthalten in: |
Zur Gesamtaufnahme - volume:384 |
---|---|
Enthalten in: |
The New England journal of medicine - 384(2021), 1 vom: 07. Jan., Seite 87 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Stone, John H [VerfasserIn] |
---|
Links: |
---|
Themen: |
Antibodies, Monoclonal, Humanized |
---|
Anmerkungen: |
Date Completed 08.01.2021 Date Revised 08.01.2021 published: Print-Electronic CommentOn: N Engl J Med. 2021 Jan 7;384(1):86-87. - PMID 33356049 Citation Status MEDLINE |
---|
doi: |
10.1056/NEJMc2032911 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM319204480 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM319204480 | ||
003 | DE-627 | ||
005 | 20231225170942.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231225s2021 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1056/NEJMc2032911 |2 doi | |
028 | 5 | 2 | |a pubmed24n1063.xml |
035 | |a (DE-627)NLM319204480 | ||
035 | |a (NLM)33356050 | ||
035 | |a (PII)10.1056/NEJMc2032911#sa2 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Stone, John H |e verfasserin |4 aut | |
245 | 1 | 0 | |a Tocilizumab in Covid-19. Reply |
264 | 1 | |c 2021 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 08.01.2021 | ||
500 | |a Date Revised 08.01.2021 | ||
500 | |a published: Print-Electronic | ||
500 | |a CommentOn: N Engl J Med. 2021 Jan 7;384(1):86-87. - PMID 33356049 | ||
500 | |a Citation Status MEDLINE | ||
650 | 4 | |a Letter | |
650 | 4 | |a Comment | |
650 | 7 | |a Antibodies, Monoclonal, Humanized |2 NLM | |
650 | 7 | |a Receptors, Interleukin-6 |2 NLM | |
650 | 7 | |a tocilizumab |2 NLM | |
650 | 7 | |a I031V2H011 |2 NLM | |
700 | 1 | |a Horick, Nora K |e verfasserin |4 aut | |
700 | 1 | |a Healy, Brian C |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t The New England journal of medicine |d 1945 |g 384(2021), 1 vom: 07. Jan., Seite 87 |w (DE-627)NLM000008184 |x 1533-4406 |7 nnns |
773 | 1 | 8 | |g volume:384 |g year:2021 |g number:1 |g day:07 |g month:01 |g pages:87 |
856 | 4 | 0 | |u http://dx.doi.org/10.1056/NEJMc2032911 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 384 |j 2021 |e 1 |b 07 |c 01 |h 87 |